Research finds exercise has a significant impact on immune cells that support brain function
New research published in Aging Cell provides insights into how exercise may help to prevent or slow cognitive decline during aging.
Noticias
Newly identified PET biomarker predicts success of immune checkpoint blockade therapy
The protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor responses before beginning treatment.
Iron fuels immune cells – and it could make asthma worse
Asthma attacks can result from immune cells overreacting to a harmless allergen. Tamping down iron levels in certain immune cells can help control their activity.
Researchers use dual drug strategy to advance melanoma treatment against resistance
Research conducted by the Centenary Institute has revealed a promising new approach to tackling melanoma, an aggressive form of skin cancer notorious for its resistance to conventional treatments.
Is ‘herd immunity’ in intensive care doing more harm than good?
Infections acquired by patients in intensive care units (ICUs) are bad news. These patients, many on life support, are already vulnerable. An infection will increase their chance of dying.
New study shows certain combinations of antiviral proteins are responsible for lupus symptoms
In a new study, researchers from Johns Hopkins Medicine say they have uncovered insights as to why lupus symptoms and severity present differently in individuals with the autoimmune condition, which affects up to 1.5 million Americans. The team says th…
Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy
In an editorial, in Oncoscience titled “Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy,” researcher Ioannis A. Voutsadakis from Sault Area Hospital and Northern Ontario School of Medicine discuss tumor mutation bu…
Breakthrough therapies are saving lives, but can we afford them?
Harnessing the body’s own cells to fight disease, long a medical dream, is finally a reality.
Study highlights need for cell-type-specific therapies in treatment of HIV
Researchers from the University of Illinois have demonstrated the importance of cell-type-specific targeting in the treatment of HIV. Their study, published in the Proceedings of the National Academy of Sciences, is one of the first to examine the diff…
Variations in ‘ancient’ immune cells linked to patients’ survival in cancer
Researchers from the Cancer Science Institute of Singapore (CSI) at the National University of Singapore (NUS), have achieved breakthroughs in understanding relapse after chemotherapy for a type of cancer known as diffuse large B-cell lymphoma (DLBCL).